NEI News

Cross-sectional images of retina from retinoschisin-deficient mice, untreated and treated with XLRS gene therapy.

The National Eye Institute (NEI) recently launched the first-ever human gene therapy trial for the vision disorder X-linked retinoschisis (XLRS). Researchers are conducting the trial at the National Institutes of Health Clinical Research Center in Bethesda, Maryland.

Posted on Apr 6, 2015
Illustration showing the retina as seen through a dilated pupil.

In an NIH-supported clinical trial comparing three drugs for diabetic macular edema (DME), Eylea (aflibercept) provided greater visual improvement, on average, than did Avastin (bevacizumab) or Lucentis (ranibizumab) when vision was 20/50 or worse at the start of the trial.

Posted on Feb 18, 2015
  • Facts About Stargardt Disease

    Stargardt disease is an inherited disorder of the retina – the tissue at the back of the eye that senses light.

  • NEI Audacious Goals Initiative

    The AGI is catalyzing research that will enable the restoration of vision through regeneration of the retina.

  • Educational Resources for Children

    We’ve developed videos and other materials to help students learn about healthy vision, eye safety, how the eyes work, and more.

  • Eye Health Infographics

    Use these graphics to share information quickly and clearly. Topics include AMD, cataract, glaucoma, diabetic retinopathy, low vision and more.

  • NIH Big Data to Knowledge (BD2K) initiative

    Enabling biomedical scientists to capitalize more fully on large, complex, and diverse datasets.